{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:23:31Z","timestamp":1778055811867,"version":"3.51.4"},"reference-count":592,"publisher":"BMJ","issue":"9","funder":[{"name":"Menarini Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2022,6,21]]},"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>\n                  <jats:italic>Helicobacter pylori<\/jats:italic>\n               <\/jats:title>\n               <jats:p>Infection is formally recognised as an infectious disease, an entity that is now included in the International Classification of Diseases 11th Revision. This in principle leads to the recommendation that all infected patients should receive treatment. In the context of the wide clinical spectrum associated with <jats:italic>Helicobacter pylori<\/jats:italic> gastritis, specific issues persist and require regular updates for optimised management.<\/jats:p>\n               <jats:p>The identification of distinct clinical scenarios, proper testing and adoption of effective strategies for prevention of gastric cancer and other complications are addressed. <jats:italic>H. pylori<\/jats:italic> treatment is challenged by the continuously rising antibiotic resistance and demands for susceptibility testing with consideration of novel molecular technologies and careful selection of first line and rescue therapies. The role of <jats:italic>H. pylori<\/jats:italic> and antibiotic therapies and their impact on the gut microbiota are also considered.<\/jats:p>\n               <jats:p>Progress made in the management of <jats:italic>H. pylori<\/jats:italic> infection is covered in the present sixth edition of the Maastricht\/Florence 2021 Consensus Report, key aspects related to the clinical role of <jats:italic>H. pylori<\/jats:italic> infection were re-evaluated and updated. Forty-one experts from 29 countries representing a global community, examined the new data related to <jats:italic>H. pylori<\/jats:italic> infection in five working groups: (1) indications\/associations, (2) diagnosis, (3) treatment, (4) prevention\/gastric cancer and (5) <jats:italic>H. pylori<\/jats:italic> and the gut microbiota. The results of the individual working groups were presented for a final consensus voting that included all participants. Recommendations are provided on the basis of the best available evidence and relevance to the management of <jats:italic>H. pylori<\/jats:italic> infection in various clinical fields.<\/jats:p>","DOI":"10.1136\/gutjnl-2022-327745","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T03:10:55Z","timestamp":1660014655000},"page":"1724-1762","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1199,"title":["Management of <i>Helicobacter pylori<\/i> infection: the Maastricht VI\/Florence consensus report"],"prefix":"10.1136","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8439-9036","authenticated-orcid":false,"given":"Peter","family":"Malfertheiner","sequence":"first","affiliation":[{"name":"Medical Department 2, LMU, Munchen, Germany"},{"name":"Department of Radiology, LMU, Munchen, Germany"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2481-1612","authenticated-orcid":false,"given":"Francis","family":"Megraud","sequence":"additional","affiliation":[{"name":"INSERM U853 UMR BaRITOn, University of Bordeaux, Bordeaux, France"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6475-3026","authenticated-orcid":false,"given":"Theodore","family":"Rokkas","sequence":"additional","affiliation":[{"name":"Gastroenterology, Henry Dunant Hospital Center, Athens, Greece"},{"name":"Medical School, European University, Nicosia, Cyprus"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2090-3445","authenticated-orcid":false,"given":"Javier P","family":"Gisbert","sequence":"additional","affiliation":[{"name":"Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigaci\u00f3n Sanitaria Princesa (IP), Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBEREHD), Madrid, Spain"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7945-5408","authenticated-orcid":false,"given":"Jyh-Ming","family":"Liou","sequence":"additional","affiliation":[{"name":"Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1841-1337","authenticated-orcid":false,"given":"Christian","family":"Schulz","sequence":"additional","affiliation":[{"name":"Medical Department 2, LMU, Munchen, Germany"},{"name":"Partner Site Munich, DZIF, Braunschweig, Germany"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[{"name":"Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore Facolt\u00e0 di Medicina e Chirurgia, Roma, Italy"}]},{"given":"Richard H","family":"Hunt","sequence":"additional","affiliation":[{"name":"Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Farncombe Family Digestive Health Research Institute, Hamilton, Ontario, Canada"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-8855","authenticated-orcid":false,"given":"Marcis","family":"Leja","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Latvia, Riga, Latvia"},{"name":"Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia"}]},{"given":"Colm","family":"O'Morain","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Trinity College Dublin, Dublin, Ireland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0679-0563","authenticated-orcid":false,"given":"Massimo","family":"Rugge","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), Surgical Pathology & Cytopathology Unit, University of Padova, Padova, Italy"},{"name":"Veneto Tumor Registry (RTV), Padova, Italy"}]},{"given":"Sebastian","family":"Suerbaum","sequence":"additional","affiliation":[{"name":"Partner Site Munich, DZIF, Braunschweig, Germany"},{"name":"Max von Pettenkofer Institute, LMU, Munchen, Germany"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-2579","authenticated-orcid":false,"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medizinische Universitat Innsbruck, Innsbruck, Austria"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8578-2974","authenticated-orcid":false,"given":"Kentaro","family":"Sugano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jichi Medical School, Tochigi, Japan"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0011-3924","authenticated-orcid":false,"given":"Emad M","family":"El-Omar","sequence":"additional","affiliation":[{"name":"UNSW Microbiome Research Centre, St George & Sutherland Clinical Campuses, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia"}]}],"member":"239","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"2025090711072529000_71.9.1724.1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312288"},{"key":"2025090711072529000_71.9.1724.2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309252"},{"key":"2025090711072529000_71.9.1724.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"2025090711072529000_71.9.1724.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39493.646875.AE"},{"key":"2025090711072529000_71.9.1724.5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cgh.2013.02.001","article-title":"The AGA Institute process for developing clinical practice guidelines part one: grading the evidence","volume":"11","author":"Sultan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/pcmedi\/pbz009","article-title":"Helicobacter pylori infection is an infectious disease and the empiric therapy paradigm should be changed","volume":"2","author":"Li","year":"2019","journal-title":"Precis Clin Med"},{"key":"2025090711072529000_71.9.1724.7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322368"},{"key":"2025090711072529000_71.9.1724.8","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199610000-00001"},{"key":"2025090711072529000_71.9.1724.9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.dld.2021.03.007","article-title":"Gastritis: the clinico-pathological spectrum","volume":"53","author":"Rugge","year":"2021","journal-title":"Dig Liver Dis"},{"key":"2025090711072529000_71.9.1724.10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1159\/000515345","article-title":"Inflammatory Cell Numbers in the Stomach of Japanese Subjects with Endoscopically Normal Mucosa without <b><i>Helicobacter pylori<\/i><\/b> Infection","volume":"39","author":"Sumi","year":"2021","journal-title":"Dig Dis"},{"key":"2025090711072529000_71.9.1724.11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad2545"},{"key":"2025090711072529000_71.9.1724.12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5694\/j.1326-5377.1985.tb113443.x","article-title":"Attempt to fulfil Koch's postulates for pyloric Campylobacter","volume":"142","author":"Marshall","year":"1985","journal-title":"Med J Aust"},{"key":"2025090711072529000_71.9.1724.13","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199905)188:1<24::AID-PATH316>3.0.CO;2-F"},{"key":"2025090711072529000_71.9.1724.14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cgh.2017.01.006","article-title":"Clinical manifestations of Helicobacter pylori-Negative gastritis","volume":"15","author":"Shiota","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MCG.0b013e31829f2e25","article-title":"Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up","volume":"48","author":"Zhao","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"2025090711072529000_71.9.1724.16","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.3748\/wjg.v22.i12.3486","article-title":"Helicobacter pylori eradication therapy for functional dyspepsia: systematic review and meta-analysis","volume":"22","author":"Du","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.17","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2013.3","article-title":"Helicobacter Pylori \"Test-and-Treat\" Strategy for Management of Dyspepsia: A Comprehensive Review","volume":"4","author":"Gisbert","year":"2013","journal-title":"Clin Transl Gastroenterol"},{"key":"2025090711072529000_71.9.1724.18","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.9"},{"key":"2025090711072529000_71.9.1724.19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01695.x"},{"key":"2025090711072529000_71.9.1724.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39479.640486.AE"},{"key":"2025090711072529000_71.9.1724.21","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12693","article-title":"Helicobacter pylori \"Test-and-Treat\" strategy with urea breath test: A cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative","volume":"25","author":"Beresniak","year":"2020","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.05.031"},{"key":"2025090711072529000_71.9.1724.23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1067\/mge.2002.122617","article-title":"Empirical treatment based on \"typical\" reflux symptoms is inappropriate in a population with a high prevalence of Helicobacter pylori infection","volume":"55","author":"JC","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"2025090711072529000_71.9.1724.24","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2001.118254"},{"key":"2025090711072529000_71.9.1724.25","first-page":"1883","article-title":"The endoscopic and clinicopathological characteristics of early-onset gastric cancer in Vietnamese patients","volume":"19","author":"Quach","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"2025090711072529000_71.9.1724.26","doi-asserted-by":"publisher","DOI":"10.1159\/000332213"},{"key":"2025090711072529000_71.9.1724.27","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.071779"},{"key":"2025090711072529000_71.9.1724.28","first-page":"195","article-title":"Helicobacter pylori modulation of gastric acid","volume":"72","author":"Calam","year":"1999","journal-title":"Yale J Biol Med"},{"key":"2025090711072529000_71.9.1724.29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/00365529609094531","article-title":"Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer","volume":"215","author":"McColl","year":"1996","journal-title":"Scand J Gastroenterol Suppl"},{"key":"2025090711072529000_71.9.1724.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(05)70138-2"},{"key":"2025090711072529000_71.9.1724.31","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.1.20"},{"key":"2025090711072529000_71.9.1724.32","first-page":"3242","article-title":"Symptom-Based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia","volume":"17","author":"Lan","year":"2011","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.33","article-title":"Eradication of Helicobacter pylori for non-ulcer dyspepsia","author":"Moayyedi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090711072529000_71.9.1724.34","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/jcm8091324","article-title":"Helicobacter pylori eradication therapy for functional dyspepsia: a meta-analysis by region and H. pylori prevalence","volume":"8","author":"Kang","year":"2019","journal-title":"JCM"},{"key":"2025090711072529000_71.9.1724.35","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2021-326583","article-title":"Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis","author":"Ford","year":"2022","journal-title":"Gut"},{"key":"2025090711072529000_71.9.1724.36","doi-asserted-by":"crossref","first-page":"l6483","DOI":"10.1136\/bmj.l6483","article-title":"Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis","volume":"51","author":"Eusebi","year":"2019","journal-title":"BMJ"},{"key":"2025090711072529000_71.9.1724.37","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.cgh.2017.06.006","article-title":"Effects of community screening for Helicobacter pylori: 13-year follow-up evaluation of a randomized controlled trial","volume":"15","author":"Bomme","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38702.662546.55"},{"key":"2025090711072529000_71.9.1724.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01770.x"},{"key":"2025090711072529000_71.9.1724.40","first-page":"222","article-title":"The diagnosis and treatment of functional dyspepsia","volume":"115","author":"Madisch","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"2025090711072529000_71.9.1724.41","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.154"},{"key":"2025090711072529000_71.9.1724.42","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3904\/kjim.2016.091","article-title":"Functional dyspepsia: new insights into pathogenesis and therapy","volume":"31","author":"Talley","year":"2016","journal-title":"Korean J Intern Med"},{"key":"2025090711072529000_71.9.1724.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60938-7"},{"key":"2025090711072529000_71.9.1724.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32404-7"},{"key":"2025090711072529000_71.9.1724.45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.7704\/kjhugr.2019.19.1.42","article-title":"Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, and low-dose aspirin therapy in peptic ulcer disease: a case-control study","volume":"19","author":"Seo","year":"2019","journal-title":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research"},{"key":"2025090711072529000_71.9.1724.46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7704\/kjhugr.2018.18.2.89","article-title":"The role of Helicobacter pylori infection in drug-induced peptic ulcer","volume":"18","author":"Koh JS","year":"2018","journal-title":"Korean J Helicobacter Up Gastrointest Res"},{"key":"2025090711072529000_71.9.1724.47","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3415-9"},{"key":"2025090711072529000_71.9.1724.48","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12805"},{"key":"2025090711072529000_71.9.1724.49","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.98"},{"key":"2025090711072529000_71.9.1724.50","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/apt.14652","article-title":"Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors","volume":"47","author":"Venerito","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.51","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13324"},{"key":"2025090711072529000_71.9.1724.52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/sjg.SJG_573_16","article-title":"Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: a meta-analysis","volume":"23","author":"Li","year":"2017","journal-title":"Saudi J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.53","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819834511","article-title":"Long-Term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence","volume":"12","author":"Cheung","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"2025090711072529000_71.9.1724.54","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-017-0577-6"},{"key":"2025090711072529000_71.9.1724.55","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.117"},{"key":"2025090711072529000_71.9.1724.56","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.2169\/internalmedicine.7964-16","article-title":"Proton pump inhibitor induction of gastric Cobblestone-like lesions in the stomach","volume":"56","author":"Takahari","year":"2017","journal-title":"Intern Med"},{"key":"2025090711072529000_71.9.1724.57","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/apt.12052","article-title":"Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the Lotus trial","volume":"36","author":"Fiocca","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02792.x"},{"key":"2025090711072529000_71.9.1724.59","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12330","article-title":"An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia","volume":"22","author":"Hudak","year":"2017","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.60","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.563"},{"key":"2025090711072529000_71.9.1724.61","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/10245332.2018.1461290","article-title":"Iron deficiency anemia referral to the hematologist. real-world data from Mexico: the need for targeted teaching in primary care","volume":"23","author":"L\u00f3pez-Garc\u00eda","year":"2018","journal-title":"Hematology"},{"key":"2025090711072529000_71.9.1724.62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/09537104.2018.1453061","article-title":"Ethnic and racial difference in Helicobacter pylori infection in patients with immune thrombocytopenia treated at a major urban medical center","volume":"30","author":"O'Neill","year":"2019","journal-title":"Platelets"},{"key":"2025090711072529000_71.9.1724.63","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.htct.2017.11.010","article-title":"Hematological parameters, serum iron and vitamin B\n                  12\n                levels in hospitalized Palestinian adult patients infected with Helicobacter pylori: a case-control study","volume":"40","author":"Mwafy","year":"2018","journal-title":"Hematol Transfus Cell Ther"},{"key":"2025090711072529000_71.9.1724.64","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.11.059","article-title":"AGA clinical practice update on the management of refractory Helicobacter pylori infection: expert review","volume":"160","author":"Shah","year":"2021","journal-title":"Gastroenterology"},{"key":"2025090711072529000_71.9.1724.65","first-page":"152","article-title":"Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","volume":"66","author":"Raderer","year":"2016","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"2025090711072529000_71.9.1724.66","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.224949"},{"key":"2025090711072529000_71.9.1724.67","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000812"},{"key":"2025090711072529000_71.9.1724.68","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12774","article-title":"Efficacy of eradication therapy in Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a meta-analysis","volume":"26","author":"Jung","year":"2021","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.69","doi-asserted-by":"crossref","first-page":"E150","DOI":"10.1002\/ajh.25447","article-title":"Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma","volume":"94","author":"Strati","year":"2019","journal-title":"Am J Hematol"},{"key":"2025090711072529000_71.9.1724.70","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12474","article-title":"Anti-Helicobacter pylori therapy in localized gastric mucosa-associated lymphoid tissue lymphoma: a prospective, nationwide, multicenter study in Japan","volume":"23","author":"Sugizaki","year":"2018","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.71","first-page":"553","article-title":"Clinical manifestations and epigenetic mechanisms of gastric mucosa associated lymphoid tissue lymphoma and long-term follow-up following Helicobacter pylori eradication","volume":"15","author":"Song","year":"2018","journal-title":"Exp Ther Med"},{"key":"2025090711072529000_71.9.1724.72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Annals of Oncology"},{"key":"2025090711072529000_71.9.1724.73","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9040132","article-title":"Helicobacter pylori strains and gastric MALT lymphoma","volume":"9","author":"Floch","year":"2017","journal-title":"Toxins"},{"key":"2025090711072529000_71.9.1724.74","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.243"},{"key":"2025090711072529000_71.9.1724.75","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12636","article-title":"Review: Helicobacter pylori and extragastric diseases","volume":"24","author":"Franceschi","year":"2019","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.76","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-018-0469-6","article-title":"H. pylori infection and extra-gastroduodenal diseases","volume":"25","author":"Tsay","year":"2018","journal-title":"J Biomed Sci"},{"key":"2025090711072529000_71.9.1724.77","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i36.12781"},{"key":"2025090711072529000_71.9.1724.78","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.3748\/wjg.v26.i28.4076","article-title":"Helicobacter pylori infection: Beyond gastric manifestations","volume":"26","author":"Santos","year":"2020","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.79","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i29.3204"},{"key":"2025090711072529000_71.9.1724.80","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1159\/000511076","article-title":"Influence of COVID-19 Pandemic on Endoscopic Procedures in Two European Large-Capacity Endoscopy Units: \u201cKeep Calm, Keep Safe and Scope on?\u201d","volume":"39","author":"Zorniak","year":"2021","journal-title":"Dig Dis"},{"key":"2025090711072529000_71.9.1724.81","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.26334","article-title":"Gastrointestinal cancer stage at diagnosis before and during the COVID-19 pandemic in Japan","volume":"4","author":"Kuzuu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025090711072529000_71.9.1724.82","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321341"},{"key":"2025090711072529000_71.9.1724.83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012080.pub2"},{"key":"2025090711072529000_71.9.1724.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.045."},{"key":"2025090711072529000_71.9.1724.85","doi-asserted-by":"crossref","unstructured":"Ferlay J , Colombet M , Soerjomataram I . Cancer statistics for the year 2020: an overview. Int J Cancer 2021. [Epub ahead of print: 05 Apr 2021].doi:10.1002\/ijc.33588","DOI":"10.1002\/ijc.33588"},{"key":"2025090711072529000_71.9.1724.86","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.036111"},{"key":"2025090711072529000_71.9.1724.87","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/a-1104-5245","article-title":"Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of gastrointestinal endoscopy (ESGE) position statement","volume":"52","author":"S\u0103ftoiu","year":"2020","journal-title":"Endoscopy"},{"key":"2025090711072529000_71.9.1724.88","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/MEG.0000000000000657","article-title":"Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis","volume":"28","author":"Pimenta-Melo","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.89","doi-asserted-by":"publisher","DOI":"10.1055\/a-0859-1883"},{"key":"2025090711072529000_71.9.1724.90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00428-011-1177-8","article-title":"Management of precancerous conditions and lesions in the stomach (maps): guideline from the European Society of gastrointestinal endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)","volume":"460","author":"Dinis-Ribeiro","year":"2012","journal-title":"Virchows Arch"},{"key":"2025090711072529000_71.9.1724.91","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-318126"},{"key":"2025090711072529000_71.9.1724.92","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1055\/s-0042-113128","article-title":"Performance measures for upper gastrointestinal endoscopy: a European Society of gastrointestinal endoscopy (ESGE) quality improvement initiative","volume":"48","author":"Bisschops","year":"2016","journal-title":"Endoscopy"},{"key":"2025090711072529000_71.9.1724.93","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1055\/a-1205-0570","article-title":"Image-enhanced endoscopy for gastric preneoplastic conditions and neoplastic lesions: a systematic review and meta-analysis","volume":"52","author":"Rodr\u00edguez-Carrasco","year":"2020","journal-title":"Endoscopy"},{"key":"2025090711072529000_71.9.1724.94","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/a-0808-3186","article-title":"Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study","volume":"51","author":"Esposito","year":"2019","journal-title":"Endoscopy"},{"key":"2025090711072529000_71.9.1724.95","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-108435"},{"key":"2025090711072529000_71.9.1724.96","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-320091"},{"key":"2025090711072529000_71.9.1724.97","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/a-0628-6601","article-title":"Prospective comparative study of endoscopic submucosal dissection and gastrectomy for early neoplastic lesions including patients\u2019 perspectives","volume":"51","author":"Lib\u00e2nio","year":"2019","journal-title":"Endoscopy"},{"key":"2025090711072529000_71.9.1724.98","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.4.459"},{"key":"2025090711072529000_71.9.1724.99","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01069.x"},{"key":"2025090711072529000_71.9.1724.100","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00557.x"},{"key":"2025090711072529000_71.9.1724.101","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01096.x"},{"key":"2025090711072529000_71.9.1724.102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00668.x"},{"key":"2025090711072529000_71.9.1724.103","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i46.7340"},{"key":"2025090711072529000_71.9.1724.104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1083-4389.2004.00235.x"},{"key":"2025090711072529000_71.9.1724.105","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.clinbiochem.2016.01.015","article-title":"Diagnostic accuracy of three monoclonal stool tests in a large series of untreated Helicobacter pylori infected patients","volume":"49","author":"Lario","year":"2016","journal-title":"Clin Biochem"},{"key":"2025090711072529000_71.9.1724.106","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12053"},{"key":"2025090711072529000_71.9.1724.107","doi-asserted-by":"publisher","DOI":"10.1086\/649860"},{"key":"2025090711072529000_71.9.1724.108","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jfma.2019.12.003","article-title":"Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan","volume":"119","author":"Fang","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"2025090711072529000_71.9.1724.109","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.gastrohep.2019.09.009","article-title":"Prospective, study comparing the accuracy of two different stool antigen tests (premier platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infection","volume":"43","author":"McNicholl","year":"2020","journal-title":"Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.110","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.42","article-title":"Pepsinogens to distinguish patients with gastric intestinal metaplasia and Helicobacter pylori infection among populations at risk for gastric cancer","volume":"7","author":"De Re","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"2025090711072529000_71.9.1724.111","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF03347456","article-title":"Serum autoimmune gastritis markers, pepsinogen I and parietal cell antibodies, in patients with type 1 diabetes mellitus: a 5-year prospective study","volume":"34","author":"Alonso","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"2025090711072529000_71.9.1724.112","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2020-139183"},{"key":"2025090711072529000_71.9.1724.113","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2015-203405"},{"key":"2025090711072529000_71.9.1724.114","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13097"},{"key":"2025090711072529000_71.9.1724.115","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/apt.15540","article-title":"Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience","volume":"50","author":"Miceli","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.116","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324032"},{"key":"2025090711072529000_71.9.1724.117","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12299"},{"key":"2025090711072529000_71.9.1724.118","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12467","article-title":"A systematic review and meta-analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori","volume":"23","author":"Wang","year":"2018","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.119","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.596371","article-title":"Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori","volume":"10","author":"Egli","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2025090711072529000_71.9.1724.120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/jcm8010053","article-title":"Genetic determinants and prediction of antibiotic resistance phenotypes in Helicobacter pylori","volume":"8","author":"Lauener","year":"2019","journal-title":"JCM"},{"key":"2025090711072529000_71.9.1724.121","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10050-1","article-title":"Within-Host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps","volume":"10","author":"Ailloud","year":"2019","journal-title":"Nat Commun"},{"key":"2025090711072529000_71.9.1724.122","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1053\/j.gastro.2022.02.027","article-title":"Comparable results of Helicobacter pylori antibiotic resistance testing of stools vs gastric biopsies using next-generation sequencing","volume":"162","author":"Moss","year":"2022","journal-title":"Gastroenterology"},{"key":"2025090711072529000_71.9.1724.123","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1053\/j.gastro.2021.02.014","article-title":"Impact of antimicrobial resistance rates on eradication of Helicobacter pylori in a US population","volume":"160","author":"Argueta","year":"2021","journal-title":"Gastroenterology"},{"key":"2025090711072529000_71.9.1724.124","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1053\/j.gastro.2021.07.012","article-title":"Comparison of culture with antibiogram to next-generation sequencing using bacterial isolates and formalin-fixed, paraffin-embedded gastric biopsies","volume":"161","author":"Hulten","year":"2021","journal-title":"Gastroenterology"},{"key":"2025090711072529000_71.9.1724.125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1751-2980.2011.00549.x","article-title":"Detection of clarithromycin resistance in Helicobacter pylori following noncryogenic storage of rapid urease tests for 30 days","volume":"13","author":"Li","year":"2012","journal-title":"J Dig Dis"},{"key":"2025090711072529000_71.9.1724.126","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.3748\/wjg.v20.i21.6547","article-title":"Dual-Priming oligonucleotide-based multiplex PCR using tissue samples in rapid urease test in the detection of Helicobacter pylori infection","volume":"20","author":"Chung","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.127","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.dld.2016.04.012","article-title":"Dual-Priming oligonucleotide-based multiplex PCR using tissue samples from the rapid urease test kit for the detection of Helicobacter pylori in bleeding peptic ulcers","volume":"48","author":"Chung","year":"2016","journal-title":"Dig Liver Dis"},{"key":"2025090711072529000_71.9.1724.128","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/676585"},{"key":"2025090711072529000_71.9.1724.129","first-page":"13","article-title":"Council recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002\/77\/EC)","volume":"45","year":"2002","journal-title":"Official Journal of the European Communities"},{"key":"2025090711072529000_71.9.1724.130","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.022111"},{"key":"2025090711072529000_71.9.1724.131","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820968736","article-title":"Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review","volume":"13","author":"Gisbert","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"key":"2025090711072529000_71.9.1724.132","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30272-5"},{"key":"2025090711072529000_71.9.1724.133","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12512","article-title":"Real\u2010time PCR for Helicobacter pylori diagnosis. The best tools available","volume":"23","author":"B\u00e9n\u00e9jat","year":"2018","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.134","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12714","article-title":"The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta\u2010analysis","volume":"25","author":"Zou","year":"2020","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.135","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.007"},{"key":"2025090711072529000_71.9.1724.136","doi-asserted-by":"crossref","first-page":"133","DOI":"10.12998\/wjcc.v9.i1.133","article-title":"Polymerase chain reaction-based tests for detecting Helicobacter pylori clarithromycin resistance in stool samples: A meta-analysis","volume":"9","author":"Gong","year":"2021","journal-title":"World J Clin Cases"},{"key":"2025090711072529000_71.9.1724.137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0016-5085(88)90606-3","article-title":"Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment","volume":"94","author":"Rauws","year":"1988","journal-title":"Gastroenterology"},{"key":"2025090711072529000_71.9.1724.138","doi-asserted-by":"publisher","DOI":"10.1023\/A:1021931627698"},{"key":"2025090711072529000_71.9.1724.139","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/00365521.2018.1476909","article-title":"Accuracy of two plasma antibody tests and faecal antigen test for non-invasive detection of H. pylori in middle-aged Caucasian general population sample","volume":"53","author":"Skrebinska","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.140","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00433-13"},{"key":"2025090711072529000_71.9.1724.141","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14660"},{"key":"2025090711072529000_71.9.1724.142","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/MOG.0000000000000576","article-title":"Diagnosis: gastric intestinal metaplasia - what to do next?","volume":"35","author":"Graham","year":"2019","journal-title":"Curr Opin Gastroenterol"},{"key":"2025090711072529000_71.9.1724.143","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01301.x"},{"key":"2025090711072529000_71.9.1724.144","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2001.01221.x"},{"key":"2025090711072529000_71.9.1724.145","doi-asserted-by":"publisher","DOI":"10.1002\/path.5066"},{"key":"2025090711072529000_71.9.1724.146","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.dld.2020.09.003","article-title":"Histological assessment of gastric pseudopyloric metaplasia: intra- and inter-observer consistency","volume":"53","author":"Rugge","year":"2021","journal-title":"Dig Liver Dis"},{"key":"2025090711072529000_71.9.1724.147","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2008.02.030"},{"key":"2025090711072529000_71.9.1724.148","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0353-8"},{"key":"2025090711072529000_71.9.1724.149","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2009.12.029"},{"key":"2025090711072529000_71.9.1724.150","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2017.1315739"},{"key":"2025090711072529000_71.9.1724.151","doi-asserted-by":"crossref","first-page":"9431","DOI":"10.12998\/wjcc.v9.i31.9431","article-title":"Association of serum pepsinogen with degree of gastric mucosal atrophy in an asymptomatic population","volume":"9","author":"Cai","year":"2021","journal-title":"World J Clin Cases"},{"key":"2025090711072529000_71.9.1724.152","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.652574","article-title":"Diagnostic value of serum pepsinogen levels for screening gastric cancer and atrophic gastritis in asymptomatic individuals: a cross-sectional study","volume":"11","author":"Tong","year":"2021","journal-title":"Front Oncol"},{"key":"2025090711072529000_71.9.1724.153","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(11)60593-8"},{"key":"2025090711072529000_71.9.1724.154","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2010.12.017"},{"key":"2025090711072529000_71.9.1724.155","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10120-018-0812-3","article-title":"The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis","volume":"21","author":"Yue","year":"2018","journal-title":"Gastric Cancer"},{"key":"2025090711072529000_71.9.1724.156","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-014-1544-3"},{"key":"2025090711072529000_71.9.1724.157","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-020-0187-8","article-title":"Autoimmune gastritis","volume":"6","author":"Lenti","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2025090711072529000_71.9.1724.158","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.3748\/wjg.v21.i42.12179","article-title":"Autoimmune gastritis: Pathologist\u2019s viewpoint","volume":"21","author":"Coati","year":"2015","journal-title":"WJG"},{"key":"2025090711072529000_71.9.1724.159","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12328-019-01074-7","article-title":"Autoimmune metaplastic atrophic gastritis and association with neuroendocrine tumors of the stomach","volume":"13","author":"Nehme","year":"2020","journal-title":"Clin J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.160","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05101.x"},{"key":"2025090711072529000_71.9.1724.161","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.166_b.x"},{"key":"2025090711072529000_71.9.1724.162","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.3748\/wjg.v26.i24.3447","article-title":"Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis","volume":"26","author":"Nieminen","year":"2020","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.163","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2019.12.003","article-title":"AGA clinical practice guidelines on management of gastric intestinal metaplasia","volume":"158","author":"Gupta","year":"2020","journal-title":"Gastroenterology"},{"key":"2025090711072529000_71.9.1724.164","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32830ce7ba"},{"key":"2025090711072529000_71.9.1724.165","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.3748\/wjg.v12.i34.5473","article-title":"-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia","volume":"12","author":"Pereira","year":"2006","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.166","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00428-013-1458-5","article-title":"First-Degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile","volume":"463","author":"Marcos-Pinto","year":"2013","journal-title":"Virchows Arch"},{"key":"2025090711072529000_71.9.1724.167","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020648","article-title":"Genetic variations in prostaglandin E2 pathway identified as susceptibility biomarkers for gastric cancer in an intermediate risk European country","volume":"22","author":"Lopes","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025090711072529000_71.9.1724.168","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309168"},{"key":"2025090711072529000_71.9.1724.169","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ebiom.2016.10.028","article-title":"Dnmt1, Dnmt3a and Dnmt3b polymorphisms associated with gastric cancer risk: a systematic review and meta-analysis","volume":"13","author":"Li","year":"2016","journal-title":"EBioMedicine"},{"key":"2025090711072529000_71.9.1724.170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.gene.2018.10.077","article-title":"Roles of Cyclooxygenase-2 gene -765G\u202f>\u202fC (rs20417) and -1195G\u202f>\u202fA (rs689466) polymorphisms in gastric cancer: A systematic review and meta-analysis","volume":"685","author":"Luo","year":"2019","journal-title":"Gene"},{"key":"2025090711072529000_71.9.1724.171","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12150"},{"key":"2025090711072529000_71.9.1724.172","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/a-1137-4721","article-title":"Digestive findings that do not require endoscopic surveillance - Reducing the burden of care: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement","volume":"52","author":"Rodr\u00edguez-de-Santiago","year":"2020","journal-title":"Endoscopy"},{"key":"2025090711072529000_71.9.1724.173","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MEG.0000000000001040","article-title":"Western long-term accuracy of serum pepsinogen-based gastric cancer screening","volume":"30","author":"Castro","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.174","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314600"},{"key":"2025090711072529000_71.9.1724.175","doi-asserted-by":"crossref","first-page":"11552","DOI":"10.3748\/wjg.v20.i33.11552","article-title":"Metachronous gastric cancer after successful Helicobacter pylori eradication","volume":"20","author":"Shiotani","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.176","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i18.5461"},{"key":"2025090711072529000_71.9.1724.177","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jgh3.12485","article-title":"Predictive value of risk score using Kyoto classification of gastritis a few years prior to diagnosis of early gastric cancer","volume":"5","author":"Fujimoto","year":"2021","journal-title":"JGH Open"},{"key":"2025090711072529000_71.9.1724.178","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314498"},{"key":"2025090711072529000_71.9.1724.179","doi-asserted-by":"crossref","first-page":"10553","DOI":"10.3748\/wjg.v21.i37.10553","article-title":"Endoscopic surveillance of gastric cancers after Helicobacter pylori eradication","volume":"21","author":"Kobayashi","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.180","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.gie.2007.10.042","article-title":"Surface pattern classification by enhanced-magnification endoscopy for identifying early gastric cancers","volume":"67","author":"Tanaka","year":"2008","journal-title":"Gastrointest Endosc"},{"key":"2025090711072529000_71.9.1724.181","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10120-021-01183-8","article-title":"Incidence and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection of undifferentiated-type early gastric cancer: Japan clinical Oncology Group study\u2014post hoc analysis of JCOG1009\/1010","volume":"24","author":"Abe","year":"2021","journal-title":"Gastric Cancer"},{"key":"2025090711072529000_71.9.1724.182","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1055\/s-0034-1392484","article-title":"Long-Term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection","volume":"47","author":"Abe","year":"2015","journal-title":"Endoscopy"},{"key":"2025090711072529000_71.9.1724.183","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1007\/s00464-021-08460-8","article-title":"Comparison of biannual and annual endoscopic gastric cancer surveillance after endoscopic resection","volume":"36","author":"Kim","year":"2022","journal-title":"Surg Endosc"},{"key":"2025090711072529000_71.9.1724.184","doi-asserted-by":"crossref","first-page":"E1144","DOI":"10.1055\/a-1201-3089","article-title":"Prognostic factors for ESD of early gastric cancers: a systematic review and meta-analysis","volume":"8","author":"De Marco","year":"2020","journal-title":"Endosc Int Open"},{"key":"2025090711072529000_71.9.1724.185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5009\/gnl19275","article-title":"Clinical outcomes of endoscopic resection for low-grade dysplasia and high-grade dysplasia on gastric pretreatment biopsy: Korea ESD Study Group","volume":"15","author":"Jeon","year":"2021","journal-title":"Gut Liver"},{"key":"2025090711072529000_71.9.1724.186","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cgh.2020.06.023","article-title":"Efficacy of endoscopic submucosal dissection for superficial gastric neoplasia in a large cohort in North America","volume":"19","author":"Ngamruengphong","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.187","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/antibiotics9100671","article-title":"Transitioning of Helicobacter pylori therapy from trial and error to antimicrobial stewardship","volume":"9","author":"Graham","year":"2020","journal-title":"Antibiotics"},{"key":"2025090711072529000_71.9.1724.188","doi-asserted-by":"crossref","first-page":"524","DOI":"10.14309\/ajg.0000000000001659","article-title":"Antimicrobial susceptibility testing for Helicobacter pylori is now widely available: when, how, why","volume":"117","author":"Graham","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.189","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.49.3031"},{"key":"2025090711072529000_71.9.1724.190","first-page":"251","article-title":"Empirical versus susceptibility-guided treatment ofHelicobacter pylori infection: a meta-analysis","volume":"8","author":"Espada","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"2025090711072529000_71.9.1724.191","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i18.5205"},{"key":"2025090711072529000_71.9.1724.192","first-page":"CD009034","article-title":"Sequential versus standard triple first-line therapy for Helicobacter pylori eradication","author":"Nyssen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090711072529000_71.9.1724.193","doi-asserted-by":"crossref","unstructured":"Gisbert JP MA . Eradication of Helicobacter pylori infection with non-bismuth quadruple concomitant therapy. In: Rahman AU , Choudhary MI , eds. Frontiers in anti-infective drug discovery Bentham science publishers, 2020: 1\u201334.","DOI":"10.2174\/9789811412387119080001"},{"key":"2025090711072529000_71.9.1724.194","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321372"},{"key":"2025090711072529000_71.9.1724.195","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2050640620972615","article-title":"European registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practice","volume":"9","author":"Nyssen","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"2025090711072529000_71.9.1724.196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14309\/ajg.0000000000001031","article-title":"Recent developments pertaining to H. pylori infection","volume":"116","author":"Howden","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.197","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014396","article-title":"High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: a systematic review and meta-analysis","volume":"98","author":"Yang","year":"2019","journal-title":"Medicine"},{"key":"2025090711072529000_71.9.1724.198","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/jgh.15294","article-title":"Rifabutin triple therapy for first\u2010line and rescue treatment of Helicobacter pylori infection: A systematic review and meta\u2010analysis","volume":"36","author":"Gingold\u2010Belfer","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.199","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10010015","article-title":"Rifabutin for the Treatment of Helicobacter Pylori Infection: A Review","volume":"10","author":"Gisbert","year":"2020","journal-title":"Pathogens"},{"key":"2025090711072529000_71.9.1724.200","doi-asserted-by":"crossref","first-page":"e751","DOI":"10.1097\/MJT.0000000000000389","article-title":"Role of bismuth in the eradication of Helicobacter pylori","volume":"24","author":"Alkim","year":"2017","journal-title":"Am J Ther"},{"key":"2025090711072529000_71.9.1724.201","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.7361"},{"key":"2025090711072529000_71.9.1724.202","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12570","article-title":"Meta-Analysis of three-in-one single capsule bismuth-containing quadruple therapy for the eradication of Helicobacter pylori","volume":"24","author":"Nyssen","year":"2019","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.203","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02248.x"},{"key":"2025090711072529000_71.9.1724.204","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12392","article-title":"Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies","volume":"22","author":"Gisbert","year":"2017","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.205","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2015.05.003"},{"key":"2025090711072529000_71.9.1724.206","unstructured":"Nyssen OP P-AA , Keco-Huerga A , Castro-Fern\u00e1ndez M . Experience with single capsule bismuth quadruple therapy in 5,000 patients from the European registry on H. pylori management (Hp-EuReg). United European Gastroenterol J 2021:321\u20132."},{"key":"2025090711072529000_71.9.1724.207","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.3442"},{"key":"2025090711072529000_71.9.1724.208","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12984"},{"key":"2025090711072529000_71.9.1724.209","first-page":"325","article-title":"Non-bismuth quadruple concomitant treatment for H. pylori eradication: systematic review and meta-analysis","volume":"9","author":"Espada","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"2025090711072529000_71.9.1724.210","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.3748\/wjg.v22.i23.5445","article-title":"Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: a meta-analysis of randomized controlled trials","volume":"22","author":"Lin","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.211","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.3748\/wjg.v22.i19.4766","article-title":"Hybrid, sequential and concomitant therapies for Helicobacter pylori eradication: a systematic review and meta-analysis","volume":"22","author":"Song","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.212","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/jgh.15034","article-title":"Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection","volume":"35","author":"Hsu","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.213","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12389","article-title":"Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta-analysis","volume":"22","author":"Jung","year":"2017","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.214","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12784","article-title":"Reverse hybrid therapy for Helicobacter pylori eradication: a systematic review and meta-analysis","volume":"26","author":"Hu","year":"2021","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.215","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MCG.0000000000001328","article-title":"10-Day versus 14-day quadruple concomitant Nonbismuth therapy for the treatment of Helicobacter pylori infection: results from a randomized prospective study in a high clarithromycin resistance country","volume":"54","author":"Apostolopoulos","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"2025090711072529000_71.9.1724.216","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12694","article-title":"Non\u2010bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: a real\u2010life study","volume":"25","author":"Romano","year":"2020","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.217","doi-asserted-by":"crossref","first-page":"973-983.e1","DOI":"10.1016\/j.cgh.2021.03.026","article-title":"Primer for development of guidelines for Helicobacter pylori therapy using antimicrobial stewardship","volume":"20","author":"Graham","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.218","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1053\/j.gastro.2021.02.057","article-title":"Molecular-Based Helicobacter pylori susceptibility testing is almost ready for prime time","volume":"160","author":"Graham","year":"2021","journal-title":"Gastroenterology"},{"key":"2025090711072529000_71.9.1724.219","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/M19-3734","article-title":"Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial","volume":"172","author":"Graham","year":"2020","journal-title":"Ann Intern Med"},{"key":"2025090711072529000_71.9.1724.220","first-page":"319","article-title":"Pylori eradication therapy in Europe: results from 30,000 cases of the European registry on H. pylori management (Hp-EuReg)","volume":"9","author":"Nyssen OP","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"2025090711072529000_71.9.1724.221","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw220"},{"key":"2025090711072529000_71.9.1724.222","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2010.08.007"},{"key":"2025090711072529000_71.9.1724.223","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12554","article-title":"Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI","volume":"24","author":"Graham","year":"2019","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.224","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2036.2008.03807.x","article-title":"Meta-Analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication","volume":"28","author":"Villoria","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.225","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12768","article-title":"The appropriate cutoff gastric pH value for Helicobacter pylori eradication with bismuth-based quadruple therapy","volume":"26","author":"Ke","year":"2021","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.226","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/apt.12014","article-title":"Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype","volume":"36","author":"Sugimoto","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.227","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000381419","article-title":"Potent gastric acid inhibition over 24 hours by 4-Times daily dosing of esomeprazole 20 Mg","volume":"91","author":"Sahara","year":"2015","journal-title":"Digestion"},{"key":"2025090711072529000_71.9.1724.228","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cgh.2014.10.036","article-title":"High-Dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection","volume":"13","author":"Yang","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"2025090711072529000_71.9.1724.229","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12762","article-title":"A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: a randomized trial","volume":"25","author":"Song","year":"2020","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.230","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.2008.S56"},{"key":"2025090711072529000_71.9.1724.231","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.39","article-title":"Potassium-Competitive acid blockers (P-CABs): are they finally ready for prime time in acid-related disease?","volume":"6","author":"Hunt","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"2025090711072529000_71.9.1724.232","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11938-020-00330-x","article-title":"Acid suppressant therapy: a step forward with potassium-competitive acid blockers","volume":"19","author":"Scarpignato","year":"2021","journal-title":"Curr Treat Options Gastroenterol"},{"key":"2025090711072529000_71.9.1724.233","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/jgh.15252","article-title":"Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance","volume":"36","author":"Graham","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.234","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/apt.14130","article-title":"Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication","volume":"46","author":"Jung","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.235","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000504939","article-title":"Effectiveness and safety of Vonoprazan versus proton pump inhibitors for second-line Helicobacter pylori eradication therapy: systematic review and meta-analysis","volume":"102","author":"Shinozaki","year":"2021","journal-title":"Digestion"},{"key":"2025090711072529000_71.9.1724.236","doi-asserted-by":"crossref","DOI":"10.1186\/s12941-018-0281-x","article-title":"Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication","volume":"17","author":"Tanabe","year":"2018","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2025090711072529000_71.9.1724.237","doi-asserted-by":"crossref","first-page":"S634","DOI":"10.14309\/01.ajg.0000779060.18666.73","article-title":"S1382 Vonoprazan Dual and Triple Therapy for Helicobacter pylori Eradication","volume":"116","author":"Chey","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.238","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/j.gastro.2018.01.018","article-title":"Update on the use of Vonoprazan: a competitive acid blocker","volume":"154","author":"Graham","year":"2018","journal-title":"Gastroenterology"},{"key":"2025090711072529000_71.9.1724.239","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311304"},{"key":"2025090711072529000_71.9.1724.240","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1053\/j.gastro.2021.04.012","article-title":"Comparative effectiveness of multiple different first-line treatment regimens for Helicobacter pylori infection: a network meta-analysis","volume":"161","author":"Rokkas","year":"2021","journal-title":"Gastroenterology"},{"key":"2025090711072529000_71.9.1724.241","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MOG.0000000000000497","article-title":"Helicobacter pylori resistance to current therapies","volume":"35","author":"Smith","year":"2019","journal-title":"Curr Opin Gastroenterol"},{"key":"2025090711072529000_71.9.1724.242","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv155"},{"key":"2025090711072529000_71.9.1724.243","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002750","article-title":"Tailored therapy versus empiric chosen treatment for Helicobacter pylori eradication: a meta-analysis","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine"},{"key":"2025090711072529000_71.9.1724.244","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks407"},{"key":"2025090711072529000_71.9.1724.245","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2147\/IDR.S185511","article-title":"Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication","volume":"11","author":"Huang","year":"2018","journal-title":"Infect Drug Resist"},{"key":"2025090711072529000_71.9.1724.246","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X15621229"},{"key":"2025090711072529000_71.9.1724.247","article-title":"Empirical second-line therapy in 5000 patients of the European registry on Helicobacter pylori management (Hp-EuReg)","author":"Nyssen","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.248","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000472"},{"key":"2025090711072529000_71.9.1724.249","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/1751-2980.12432","article-title":"Efficacy and safety of high-dose dual therapy for Helicobacter pylori rescue therapy: a systematic review and meta-analysis","volume":"17","author":"Gao","year":"2016","journal-title":"J Dig Dis"},{"key":"2025090711072529000_71.9.1724.250","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820937115","article-title":"High dose PPI-amoxicillin dual therapy for the treatment of Helicobacter pylori infection: a systematic review with meta-analysis","volume":"13","author":"Zhu","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"key":"2025090711072529000_71.9.1724.251","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.782286"},{"key":"2025090711072529000_71.9.1724.252","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.3390\/molecules25215084","article-title":"Optimization strategies aimed to increase the efficacy of Helicobacter pylori eradication therapies with quinolones","volume":"25","author":"Gisbert","year":"2020","journal-title":"Molecules"},{"key":"2025090711072529000_71.9.1724.253","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13128"},{"key":"2025090711072529000_71.9.1724.254","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jgh.14462","article-title":"Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication","volume":"34","author":"Yeo","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.255","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7704\/kjhugr.2020.0053","article-title":"Salvage regimens after failure of previous Helicobacter pylori eradication therapy: a systematic review and meta-analysis","volume":"21","author":"Yang","year":"2021","journal-title":"Korean J Helicobacter Up Gastrointest Res"},{"key":"2025090711072529000_71.9.1724.256","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12692","article-title":"PPI-amoxicillin dual therapy for Helicobacter pylori infection: an update based on a systematic review and meta-analysis","volume":"25","author":"Gao","year":"2020","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.257","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-007-0807-2"},{"key":"2025090711072529000_71.9.1724.258","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1037345"},{"key":"2025090711072529000_71.9.1724.259","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s10620-017-4564-4","article-title":"Randomized clinical trial: esomeprazole, bismuth, levofloxacin, and amoxicillin or cefuroxime as first-line eradication regimens for Helicobacter pylori infection","volume":"62","author":"Fu","year":"2017","journal-title":"Dig Dis Sci"},{"key":"2025090711072529000_71.9.1724.260","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-27482-2","article-title":"Efficacy of two different dosages of levofloxacin in curing Helicobacter pylori infection: a prospective, single-center, randomized clinical trial","volume":"8","author":"Gan","year":"2018","journal-title":"Sci Rep"},{"key":"2025090711072529000_71.9.1724.261","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2008.01951.x"},{"key":"2025090711072529000_71.9.1724.262","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1159\/000484930","article-title":"Comparison of Helicobacter pylori eradication rates of 2-week Levofloxacin-Containing triple therapy, Levofloxacin-Containing bismuth quadruple therapy, and standard bismuth quadruple therapy as a first-line regimen","volume":"26","author":"Kahramano\u011flu Aksoy","year":"2017","journal-title":"Med Princ Pract"},{"key":"2025090711072529000_71.9.1724.263","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12052"},{"key":"2025090711072529000_71.9.1724.264","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.dld.2016.01.002","article-title":"Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy","volume":"48","author":"Song","year":"2016","journal-title":"Dig Liver Dis"},{"key":"2025090711072529000_71.9.1724.265","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03452.x"},{"key":"2025090711072529000_71.9.1724.266","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40265-017-0730-4","article-title":"Efficacy and safety of Quinolone-Containing rescue therapies after the failure of Non-Bismuth quadruple treatments for Helicobacter pylori eradication: systematic review and meta-analysis","volume":"77","author":"Marin","year":"2017","journal-title":"Drugs"},{"key":"2025090711072529000_71.9.1724.267","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3748\/wjg.v26.i15.1733","article-title":"Update on quinolone-containing rescue therapies for Helicobacter pylori infection","volume":"26","author":"Mori","year":"2020","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.268","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(03)00059-8"},{"key":"2025090711072529000_71.9.1724.269","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1523-5378.2011.00867.x","article-title":"Randomized Trial on 14 versus 7\u2003days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection","volume":"16","author":"Miehlke","year":"2011","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.270","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/2050640617737215","article-title":"Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimens","volume":"6","author":"Mori","year":"2018","journal-title":"United European Gastroenterology Journal"},{"key":"2025090711072529000_71.9.1724.271","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1159\/000501610","article-title":"10-Year trends in Helicobacter pylori eradication rates by Sitafloxacin-Based third-line rescue therapy","volume":"101","author":"Mori","year":"2020","journal-title":"Digestion"},{"key":"2025090711072529000_71.9.1724.272","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/jgh.14456","article-title":"Randomized trial of vonoprazan-based versus proton-pump inhibitor-based third-line triple therapy with sitafloxacin for Helicobacter pylori","volume":"34","author":"Sue","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.273","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12755","article-title":"Efficacy of bismuth-based quadruple therapy for eradication of Helicobacter pylori infection based on previous antibiotic exposure: a large-scale prospective, single-center clinical trial in China","volume":"25","author":"Zhou","year":"2020","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.274","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2036.2005.02522.x","article-title":"A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses","volume":"22","author":"Gatta","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.275","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00457.x"},{"key":"2025090711072529000_71.9.1724.276","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03149.x"},{"key":"2025090711072529000_71.9.1724.277","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.87"},{"key":"2025090711072529000_71.9.1724.278","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1365-2036.2012.05117.x","article-title":"Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection","volume":"35","author":"Gisbert","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.279","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ygh2.372","article-title":"Empirical Helicobacter pylori rescue therapy: an 18\u2010year single\u2010centre study of 1200 patients","volume":"1","author":"Burgos\u2010Santamar\u00eda","year":"2019","journal-title":"GastroHep"},{"key":"2025090711072529000_71.9.1724.280","first-page":"38","article-title":"European registry on H. pylori management (Hp-EuReg): analysis of 1,782 empirical rescue therapies on third and subsequent lines","volume":"8","author":"Niv","year":"2020","journal-title":"United European Gastroenterology Journal"},{"key":"2025090711072529000_71.9.1724.281","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2014.99"},{"key":"2025090711072529000_71.9.1724.282","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12722","article-title":"Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori registry (Hp-EuReg)","volume":"25","author":"Nyssen","year":"2020","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.283","doi-asserted-by":"crossref","first-page":"225","DOI":"10.15403\/jgld.2014.1121.263.zul","article-title":"Bismuth-based quadruple therapy following H. pylori eradication failures: a multicenter study in clinical practice","volume":"26","author":"Zullo","year":"2017","journal-title":"JGLD"},{"key":"2025090711072529000_71.9.1724.284","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12808"},{"key":"2025090711072529000_71.9.1724.285","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.clinre.2015.12.012","article-title":"Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains","volume":"40","author":"Muller","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2025090711072529000_71.9.1724.286","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12423","article-title":"Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera\u00ae) in third-line recue treatment for Helicobacter pylori infection. A real-life multicenter study","volume":"22","author":"Rodr\u00edguez de Santiago","year":"2017","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.287","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12686","article-title":"Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)","volume":"25","author":"Nyssen","year":"2020","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.288","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/jcm8020199","article-title":"Rifabutin-Based rescue therapy for Helicobacter pylori eradication: a long-term prospective study in a large cohort of difficult-to-treat patients","volume":"8","author":"Ribaldone","year":"2019","journal-title":"J Clin Med"},{"key":"2025090711072529000_71.9.1724.289","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1807761"},{"key":"2025090711072529000_71.9.1724.290","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-2549-1"},{"key":"2025090711072529000_71.9.1724.291","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02687.x"},{"key":"2025090711072529000_71.9.1724.292","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2009.06.007"},{"key":"2025090711072529000_71.9.1724.293","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12485","article-title":"Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance","volume":"23","author":"Long","year":"2018","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.294","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12374","article-title":"Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin","volume":"22","author":"Ono","year":"2017","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.295","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-019-1056-3","article-title":"Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin","volume":"19","author":"Song","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"2025090711072529000_71.9.1724.296","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/2050640616688995","article-title":"Antibiotic resistance and gyrA mutation affect the efficacy of 10\u2010day sitafloxacin\u2010metronidazole\u2010esomeprazole therapy for Helicobacter pylori in penicillin allergic patients","volume":"5","author":"Mori","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"2025090711072529000_71.9.1724.297","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183980","article-title":"A significant increase in the pepsinogen I\/II ratio is a reliable biomarker for successful Helicobacter pylori eradication","volume":"12","author":"Osumi","year":"2017","journal-title":"PLoS One"},{"key":"2025090711072529000_71.9.1724.298","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.028"},{"key":"2025090711072529000_71.9.1724.299","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10120-018-0876-0","article-title":"Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis","volume":"22","author":"Sugano","year":"2019","journal-title":"Gastric Cancer"},{"key":"2025090711072529000_71.9.1724.300","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320839"},{"key":"2025090711072529000_71.9.1724.301","unstructured":"Park JY GE , Parsonnet J , Wild CP . Summary of IARC Working Group Meeting on Helicobacter pylori eradication as a strategy for preventing gastric cancer. In: IARC Helicobacter pylori Working group Helicobacter pylori eradication as a strategy for preventing gastric cancer (IARC Working group reports, no 8. Lyon, France: International Agency for Research on Cancer, 2014: 1\u20134. http:\/\/www.iarc.fr\/en\/publications\/pdfs-online\/wrk\/wrk8\/index.php"},{"key":"2025090711072529000_71.9.1724.302","doi-asserted-by":"publisher","DOI":"10.1111\/den.12471"},{"key":"2025090711072529000_71.9.1724.303","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.4.429"},{"key":"2025090711072529000_71.9.1724.304","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3748\/wjg.v20.i6.1503","article-title":"Helicobacter pylori and gastric cancer: Indian enigma","volume":"20","author":"Misra","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.305","unstructured":"Cancer WCoTEBDsttEDSTLFIAfRo . Who classification of tumours series. 1. 5th ed, 2019."},{"key":"2025090711072529000_71.9.1724.306","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-010-9707-2"},{"key":"2025090711072529000_71.9.1724.307","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1351-x"},{"key":"2025090711072529000_71.9.1724.308","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/apt.15675","article-title":"Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions","volume":"51","author":"Gantuya","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.309","unstructured":"Bosman FT , Hruban RH , Theise ND , eds. Who classification of tumours of the digestive system. 4th ed. WHO Press, International Agency for Research on Cancer, 2010."},{"key":"2025090711072529000_71.9.1724.310","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327281"},{"key":"2025090711072529000_71.9.1724.311","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.186825"},{"key":"2025090711072529000_71.9.1724.312","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.137364"},{"key":"2025090711072529000_71.9.1724.313","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.114504"},{"key":"2025090711072529000_71.9.1724.314","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr384"},{"key":"2025090711072529000_71.9.1724.315","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28999"},{"key":"2025090711072529000_71.9.1724.316","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"The Lancet Global Health"},{"key":"2025090711072529000_71.9.1724.317","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000290"},{"key":"2025090711072529000_71.9.1724.318","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-19-0238"},{"key":"2025090711072529000_71.9.1724.319","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1053\/j.gastro.2019.10.019","article-title":"Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: a large cohort study","volume":"158","author":"Kumar","year":"2020","journal-title":"Gastroenterology"},{"key":"2025090711072529000_71.9.1724.320","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12483","article-title":"The epidemiology of Helicobacter pylori infection in Europe and the impact of lifestyle on its natural evolution toward stomach cancer after infection: a systematic review","volume":"23","author":"Venneman","year":"2018","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.321","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/his.13715","article-title":"Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management","volume":"73","author":"Rocha","year":"2018","journal-title":"Histopathology"},{"key":"2025090711072529000_71.9.1724.322","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.09.026"},{"key":"2025090711072529000_71.9.1724.323","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s10120-018-00912-w","article-title":"Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer","volume":"22","author":"Funakoshi","year":"2019","journal-title":"Gastric Cancer"},{"key":"2025090711072529000_71.9.1724.324","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2009.01163.x"},{"key":"2025090711072529000_71.9.1724.325","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2002.010447"},{"key":"2025090711072529000_71.9.1724.326","first-page":"67","article-title":"The incidence of neoplasia in patients with autoimmune metaplastic atrophic gastritis: a renewed call for surveillance","volume":"32","author":"Mahmud","year":"2019","journal-title":"Ann Gastroenterol"},{"key":"2025090711072529000_71.9.1724.327","unstructured":"3 National Cancer Institute . Cancer STAT facts: stomach cancer (accessed October 22."},{"key":"2025090711072529000_71.9.1724.328","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930201)71:3<745::AID-CNCR2820710316>3.0.CO;2-1"},{"key":"2025090711072529000_71.9.1724.329","doi-asserted-by":"publisher","DOI":"10.1080\/00365529850166266"},{"key":"2025090711072529000_71.9.1724.330","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/2050640619891580","article-title":"Gastric cancer in autoimmune gastritis: a case-control study from the German centers of the staR project on gastric cancer research","volume":"8","author":"Weise","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"2025090711072529000_71.9.1724.331","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamaoncol.2021.5395","article-title":"Association of Antiparietal cell and anti-intrinsic factor antibodies with risk of gastric cancer","volume":"8","author":"Song","year":"2022","journal-title":"JAMA Oncol"},{"key":"2025090711072529000_71.9.1724.332","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70355-6"},{"key":"2025090711072529000_71.9.1724.333","doi-asserted-by":"publisher","DOI":"10.1038\/nature13480"},{"key":"2025090711072529000_71.9.1724.334","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07013-x"},{"key":"2025090711072529000_71.9.1724.335","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/bjc.2015.175","article-title":"Case\u2013control study of Epstein\u2013Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease","volume":"112","author":"C\u00e1rdenas-Mondrag\u00f3n","year":"2015","journal-title":"Br J Cancer"},{"key":"2025090711072529000_71.9.1724.336","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062850"},{"key":"2025090711072529000_71.9.1724.337","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9020104","article-title":"Epstein-Barr Virus and Helicobacter Pylori Co-Infection in Non-Malignant Gastroduodenal Disorders","volume":"9","author":"D\u00e1vila-Collado","year":"2020","journal-title":"Pathogens"},{"key":"2025090711072529000_71.9.1724.338","doi-asserted-by":"publisher","DOI":"10.3109\/00365520903575737"},{"key":"2025090711072529000_71.9.1724.339","first-page":"11","article-title":"A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication","volume":"116","author":"Zhou","year":"2003","journal-title":"Chin Med J"},{"key":"2025090711072529000_71.9.1724.340","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-2001-15968","article-title":"Short-Term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients","volume":"39","author":"Plein","year":"2001","journal-title":"Z Gastroenterol"},{"key":"2025090711072529000_71.9.1724.341","first-page":"281","article-title":"Changes in the gastric mucosa following eradication of Helicobacter pylori","volume":"6","author":"Genta","year":"1993","journal-title":"Mod Pathol"},{"key":"2025090711072529000_71.9.1724.342","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302240"},{"key":"2025090711072529000_71.9.1724.343","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322200"},{"key":"2025090711072529000_71.9.1724.344","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2007.00563.x"},{"key":"2025090711072529000_71.9.1724.345","doi-asserted-by":"publisher","DOI":"10.1159\/000280318"},{"key":"2025090711072529000_71.9.1724.346","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-015-0462-7"},{"key":"2025090711072529000_71.9.1724.347","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124725","article-title":"Helicobacter pylori eradication on the prevention of metachronous lesions after endoscopic resection of gastric neoplasm: a meta-analysis","volume":"10","author":"Jung","year":"2015","journal-title":"PLoS One"},{"key":"2025090711072529000_71.9.1724.348","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708423"},{"key":"2025090711072529000_71.9.1724.349","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-011-0504-9"},{"key":"2025090711072529000_71.9.1724.350","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/apt.14424","article-title":"Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years","volume":"47","author":"Hwang","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.351","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12740","article-title":"Review: prevention and management of gastric cancer","volume":"25 Suppl 1","author":"Venerito","year":"2020","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.352","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","article-title":"Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial","volume":"372","author":"Fukase","year":"2008","journal-title":"The Lancet"},{"key":"2025090711072529000_71.9.1724.353","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5016"},{"key":"2025090711072529000_71.9.1724.354","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12185"},{"key":"2025090711072529000_71.9.1724.355","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12563","article-title":"Cost-Effectiveness analysis of screen-and-treat strategy in asymptomatic Chinese for preventing Helicobacter pylori-associated diseases","volume":"24","author":"Chen","year":"2019","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.356","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.61"},{"key":"2025090711072529000_71.9.1724.357","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJMe1800147","article-title":"Helicobacter pylori Treatment for Gastric Cancer Prevention","volume":"378","author":"Malfertheiner","year":"2018","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025090711072529000_71.9.1724.358","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.03.028"},{"key":"2025090711072529000_71.9.1724.359","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.2.187"},{"key":"2025090711072529000_71.9.1724.360","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/apt.16272","article-title":"Applications of machine learning models in the prediction of gastric cancer risk in patients after Helicobacter pylori eradication","volume":"53","author":"Leung","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.361","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.gie.2016.03.791","article-title":"Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication","volume":"84","author":"Shichijo","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"2025090711072529000_71.9.1724.362","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324057"},{"key":"2025090711072529000_71.9.1724.363","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2020.11.017","article-title":"The Colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions","volume":"160","author":"Piazuelo","year":"2021","journal-title":"Gastroenterology"},{"key":"2025090711072529000_71.9.1724.364","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000369185","article-title":"Preneoplastic conditions in the stomach: always a point of NO return","volume":"33","author":"Venerito","year":"2014","journal-title":"Dig Dis"},{"key":"2025090711072529000_71.9.1724.365","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.04.052"},{"key":"2025090711072529000_71.9.1724.366","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/jgh.15477","article-title":"Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long\u2010term prospective follow\u2010up study","volume":"36","author":"Kodama","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.367","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1710945"},{"key":"2025090711072529000_71.9.1724.368","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10096-018-3414-4","article-title":"Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations","volume":"38","author":"Sabbagh","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025090711072529000_71.9.1724.369","article-title":"New rapid Helicobacter pylori blood test based on dual detection of fliD and cagA antibodies for on-site testing","author":"Schulz","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.370","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/2050640616642341","article-title":"Family history is an independent risk factor for the progression of gastric atrophy among patients with Helicobacter pylori infection","volume":"5","author":"Nishizawa","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"2025090711072529000_71.9.1724.371","first-page":"1","article-title":"Clinicopathologic characteristics and long-term outcome of gastric cancer patients with family history: seven-year follow-up study for Korean health Check-Up subjects","volume":"2020","author":"Lee","year":"2020","journal-title":"Gastroenterol Res Pract"},{"key":"2025090711072529000_71.9.1724.372","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07612-8","article-title":"Prevalence of gastric cancer precursors in gastroscopy-screened adults by family history of gastric cancer and of cancers other than gastric","volume":"20","author":"Wu","year":"2020","journal-title":"BMC Cancer"},{"key":"2025090711072529000_71.9.1724.373","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"2025090711072529000_71.9.1724.374","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3099-4","article-title":"The magnitude of antibiotic resistance to Helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics: systematic review and meta-analysis","volume":"18","author":"Jaka","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2025090711072529000_71.9.1724.375","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2468-1253(17)30219-4","article-title":"Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis","volume":"2","author":"Kuo","year":"2017","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"2025090711072529000_71.9.1724.376","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.24"},{"key":"2025090711072529000_71.9.1724.377","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30753-191"},{"key":"2025090711072529000_71.9.1724.378","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1007\/s10620-019-05893-z","article-title":"What would the Screen-and-Treat strategy for Helicobacter pylori mean in terms of antibiotic consumption?","volume":"65","author":"Leja","year":"2020","journal-title":"Dig Dis Sci"},{"key":"2025090711072529000_71.9.1724.379","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.04.011"},{"key":"2025090711072529000_71.9.1724.380","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70024-6"},{"key":"2025090711072529000_71.9.1724.381","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/gut.2003.019844","article-title":"Effect of Helicobacter pylori eradication on the treatment of gastro-oesophageal reflux disease","volume":"53","author":"Richter","year":"2004","journal-title":"Gut"},{"key":"2025090711072529000_71.9.1724.382","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/gut.2003.019836","article-title":"Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease","volume":"53","author":"Malfertheiner","year":"2004","journal-title":"Gut"},{"key":"2025090711072529000_71.9.1724.383","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3748\/wjg.v19.i6.786","article-title":"Helicobacter pylori eradication and reflux disease onset: did gastric acid get \"crazy\"?","volume":"19","author":"Zullo","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.384","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/apt.15677","article-title":"Oesophageal and proximal gastric adenocarcinomas are rare after detection of Helicobacter pylori infection","volume":"51","author":"Kumar","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.385","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/apt.16585","article-title":"Systematic review with meta-analysis: association of Helicobacter pylori infection with gastro-oesophageal reflux and its complications","volume":"54","author":"Zamani","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.386","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12688","article-title":"Helicobacter pylori eradication treatment and the risk of Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"25","author":"Doorakkers","year":"2020","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.387","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.cgh.2019.01.013","article-title":"Association between Helicobacter pylori exposure and decreased odds of eosinophilic Esophagitis-A systematic review and meta-analysis","volume":"17","author":"Shah","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.388","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.cgh.2018.12.014","article-title":"Effects of anti-Helicobacter pylori therapy on incidence of autoimmune diseases, including inflammatory bowel diseases","volume":"17","author":"Lin","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.389","doi-asserted-by":"crossref","first-page":"119","DOI":"10.15403\/jgld.2014.1121.272.hpy","article-title":"Helicobacter pylori eradication therapy is not associated with the onset of inflammatory bowel diseases. A case-control study","volume":"27","author":"Rosania","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"key":"2025090711072529000_71.9.1724.390","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13550"},{"key":"2025090711072529000_71.9.1724.391","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/jgh.13911","article-title":"Helicobacter pylori management in ASEAN: The Bangkok consensus report","volume":"33","author":"Mahachai","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.392","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07273-2"},{"key":"2025090711072529000_71.9.1724.393","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2468-1253(21)00192-8","article-title":"Gastrointestinal bleeding in patients with Helicobacter pylori and dual platelet inhibition after myocardial infarction","volume":"6","author":"Hellstr\u00f6m","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.394","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ahj.2020.10.072","article-title":"Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction","volume":"231","author":"W\u00e4rme","year":"2021","journal-title":"Am Heart J"},{"key":"2025090711072529000_71.9.1724.395","doi-asserted-by":"publisher","DOI":"10.1080\/00365520600863720"},{"key":"2025090711072529000_71.9.1724.396","first-page":"4129","article-title":"Prevalence of H. pylori infection and atrophic gastritis in a population-based screening with serum biomarker panel (GastroPanel\u00ae) in St. Petersburg","volume":"36","author":"Roman","year":"2016","journal-title":"Anticancer Res"},{"key":"2025090711072529000_71.9.1724.397","doi-asserted-by":"publisher","DOI":"10.1515\/raon-2017-0054"},{"key":"2025090711072529000_71.9.1724.398","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123854","article-title":"Combined gastric and colorectal cancer Screening\u2014A new strategy","volume":"19","author":"Selgrad","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2025090711072529000_71.9.1724.399","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14248"},{"key":"2025090711072529000_71.9.1724.400","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(96)01501-2","article-title":"Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials","volume":"348","author":"Parsonnet","year":"1996","journal-title":"The Lancet"},{"key":"2025090711072529000_71.9.1724.401","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12050"},{"key":"2025090711072529000_71.9.1724.402","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpg.2021.101735","article-title":"Cost-Effectiveness of prevention and early detection of gastric cancer in Western countries","volume":"50-51","author":"Lansdorp-Vogelaar","year":"2021","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2025090711072529000_71.9.1724.403","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0758"},{"key":"2025090711072529000_71.9.1724.404","first-page":"105","article-title":"Hellenic consensus on Helicobacter pylori infection","volume":"33","author":"Georgopoulos","year":"2020","journal-title":"Ann Gastroenterol"},{"key":"2025090711072529000_71.9.1724.405","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/den.12483","article-title":"OLGA- and OLGIM-based staging of gastritis using narrow-band imaging magnifying endoscopy","volume":"27","author":"Saka","year":"2015","journal-title":"Dig Endosc"},{"key":"2025090711072529000_71.9.1724.406","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MCG.0000000000001195","article-title":"Does Helicobacter pylori eradication reduce the incidence of metachronous gastric cancer after curative endoscopic resection of early gastric cancer","volume":"54","author":"Zhao","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"2025090711072529000_71.9.1724.407","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs003"},{"key":"2025090711072529000_71.9.1724.408","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.23.1881"},{"key":"2025090711072529000_71.9.1724.409","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.072009"},{"key":"2025090711072529000_71.9.1724.410","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4251\/wjgo.v10.i5.115","article-title":"Risk of gastric cancer development after eradication of Helicobacter pylori","volume":"10","author":"Cheung","year":"2018","journal-title":"World J Gastrointest Oncol"},{"key":"2025090711072529000_71.9.1724.411","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0577"},{"key":"2025090711072529000_71.9.1724.412","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/cncr.33412","article-title":"Nonaspirin nonsteroidal anti-inflammatory drugs and gastric cancer risk after Helicobacter pylori eradication: a territory-wide study","volume":"127","author":"Li","year":"2021","journal-title":"Cancer"},{"key":"2025090711072529000_71.9.1724.413","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323845"},{"key":"2025090711072529000_71.9.1724.414","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325097"},{"key":"2025090711072529000_71.9.1724.415","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211051463","article-title":"Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review with meta-analysis","volume":"14","author":"Segna","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"2025090711072529000_71.9.1724.416","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001167"},{"key":"2025090711072529000_71.9.1724.417","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5009\/gnl15091","article-title":"Mass eradication of Helicobacter pylori to prevent gastric cancer: theoretical and practical considerations","volume":"10","author":"Lee","year":"2016","journal-title":"Gut Liver"},{"key":"2025090711072529000_71.9.1724.418","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1016\/j.cgh.2020.07.031","article-title":"Endoscopy for gastric cancer screening is cost effective for Asian Americans in the United States","volume":"18","author":"Shah","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.419","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309197"},{"key":"2025090711072529000_71.9.1724.420","unstructured":"Choi IJ , Herrero R . Effect of Helicobacter pylori eradication on gastric cancer prevention in the Republic of Korea: a randomized controlled clinical trial. In: IARC Helicobacter pylori Working group Helicobacter pylori eradication as a strategy for preventing gastric cancer IARC Working group reports. Lyon, France: International Agency for Research on Cancer, 2014: 154\u201360. http:\/\/wwwiarcfr\/en\/publications\/pdfs-online\/wrk\/wrk8\/indexphp"},{"key":"2025090711072529000_71.9.1724.421","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016999"},{"key":"2025090711072529000_71.9.1724.422","unstructured":"International Agency for Research on Cancer . P. M. Feasibility and cost effectiveness of population-based H. pylori eradication. In: IARC Helicobacter pylori Working group Helicobacter pylori eradication as a strategy for preventing gastric cancer (IARC Working group reports, no 8. Lyon, France: International Agency for Research on Cancer, 2014: 111\u201321. http:\/\/www.iarc.fr\/en\/publications\/pdfs-online\/wrk\/wrk8\/index.php"},{"key":"2025090711072529000_71.9.1724.423","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2013.09.005"},{"key":"2025090711072529000_71.9.1724.424","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cgh.2019.05.032","article-title":"Increased incidence and mortality of gastric cancer in immigrant populations from high to low regions of incidence: a systematic review and meta-analysis","volume":"18","author":"Pabla","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"2025090711072529000_71.9.1724.425","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.3748\/wjg.v24.i26.2818","article-title":"Biomarkers of gastric cancer: current topics and future perspective","volume":"24","author":"Matsuoka","year":"2018","journal-title":"WJG"},{"key":"2025090711072529000_71.9.1724.426","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2018.1489233"},{"key":"2025090711072529000_71.9.1724.427","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307094"},{"key":"2025090711072529000_71.9.1724.428","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133906","article-title":"Zic1 promoter hypermethylation in plasma DNA is a potential biomarker for gastric cancer and intraepithelial neoplasia","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"2025090711072529000_71.9.1724.429","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00535-018-1515-6","article-title":"Linked color imaging can enhance recognition of early gastric cancer by high color contrast to surrounding gastric intestinal metaplasia","volume":"54","author":"Fukuda","year":"2019","journal-title":"J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.430","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.gie.2018.08.049","article-title":"Blue laser imaging-bright improves the real-time detection rate of early gastric cancer: a randomized controlled study","volume":"89","author":"Dohi","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"2025090711072529000_71.9.1724.431","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/den.13585","article-title":"Comparison of endoscopic visibility and miss rate for early gastric cancers after Helicobacter pylori eradication with white-light imaging versus linked color imaging","volume":"32","author":"Kitagawa","year":"2020","journal-title":"Dig Endosc"},{"key":"2025090711072529000_71.9.1724.432","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/M19-2561","article-title":"Linked Color Imaging Focused on Neoplasm Detection in the Upper Gastrointestinal Tract : A Randomized Trial","volume":"174","author":"Ono","year":"2021","journal-title":"Ann Intern Med"},{"key":"2025090711072529000_71.9.1724.433","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1007\/s10620-020-06289-0","article-title":"Linked color imaging can improve detection rate of early gastric cancer in a high-risk population: a multi-center randomized controlled clinical trial","volume":"66","author":"Gao","year":"2021","journal-title":"Dig Dis Sci"},{"key":"2025090711072529000_71.9.1724.434","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/den.12757","article-title":"Linked color imaging enhances gastric cancer in gastric intestinal metaplasia","volume":"29","author":"Ono","year":"2017","journal-title":"Dig Endosc"},{"key":"2025090711072529000_71.9.1724.435","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00535-020-01734-3","article-title":"Near-focus magnification and second-generation narrow-band imaging for early gastric cancer in a randomized trial","volume":"55","author":"Kakushima","year":"2020","journal-title":"J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.436","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319631"},{"key":"2025090711072529000_71.9.1724.437","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.62"},{"key":"2025090711072529000_71.9.1724.438","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1016\/j.vaccine.2018.01.001","article-title":"Status of vaccine research and development for Helicobacter pylori","volume":"37","author":"Sutton","year":"2019","journal-title":"Vaccine"},{"key":"2025090711072529000_71.9.1724.439","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2468-1253(18)30125-0","article-title":"Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1\/2 study","volume":"3","author":"Malfertheiner","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.440","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60310-5"},{"key":"2025090711072529000_71.9.1724.441","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad7121","article-title":"Antibiotics, birth mode, and diet shape microbiome maturation during early life","volume":"8","author":"Bokulich","year":"2016","journal-title":"Sci Transl Med"},{"key":"2025090711072529000_71.9.1724.442","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312297"},{"key":"2025090711072529000_71.9.1724.443","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/s41564-018-0257-9","article-title":"Recovery of gut microbiota of healthy adults following antibiotic exposure","volume":"3","author":"Palleja","year":"2018","journal-title":"Nat Microbiol"},{"key":"2025090711072529000_71.9.1724.444","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10410"},{"key":"2025090711072529000_71.9.1724.445","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-0761-5"},{"key":"2025090711072529000_71.9.1724.446","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad0917","article-title":"Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability","volume":"8","author":"Yassour","year":"2016","journal-title":"Sci Transl Med"},{"key":"2025090711072529000_71.9.1724.447","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41564-019-0550-2","article-title":"Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome","volume":"4","author":"Gasparrini","year":"2019","journal-title":"Nat Microbiol"},{"key":"2025090711072529000_71.9.1724.448","doi-asserted-by":"crossref","first-page":"e02820","DOI":"10.1128\/mBio.02820-19","article-title":"Long-Term effects of early-life antibiotic exposure on resistance to subsequent bacterial infection","volume":"10","author":"Roubaud-Baudron","year":"2019","journal-title":"mBio"},{"key":"2025090711072529000_71.9.1724.449","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.05.052"},{"key":"2025090711072529000_71.9.1724.450","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.246"},{"key":"2025090711072529000_71.9.1724.451","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000443353","article-title":"Helicobacter pylori and other gastric microbiota in gastroduodenal pathologies","volume":"34","author":"Schulz","year":"2016","journal-title":"Dig Dis"},{"key":"2025090711072529000_71.9.1724.452","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01261","article-title":"Mucosa-Associated microbiota in gastric cancer tissues compared with non-cancer tissues","volume":"10","author":"Chen","year":"2019","journal-title":"Front Microbiol"},{"key":"2025090711072529000_71.9.1724.453","doi-asserted-by":"crossref","DOI":"10.1038\/srep18594","article-title":"Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"2025090711072529000_71.9.1724.454","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpg.2021.101734","article-title":"The influence of the gastric microbiota in gastric cancer development","volume":"50-51","author":"Pereira-Marques","year":"2021","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2025090711072529000_71.9.1724.455","doi-asserted-by":"publisher","DOI":"10.4161\/gmic.26205"},{"key":"2025090711072529000_71.9.1724.456","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506655103"},{"key":"2025090711072529000_71.9.1724.457","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312904"},{"key":"2025090711072529000_71.9.1724.458","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1053\/j.gastro.2019.05.068","article-title":"Analysis of transcriptionally active bacteria throughout the gastrointestinal tract of healthy individuals","volume":"157","author":"Vasapolli","year":"2019","journal-title":"Gastroenterology"},{"key":"2025090711072529000_71.9.1724.459","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040504","article-title":"Gastric microbiota in Helicobacter pylori-Negative and -positive gastritis among high incidence of gastric cancer area","volume":"11","author":"Gantuya","year":"2019","journal-title":"Cancers"},{"key":"2025090711072529000_71.9.1724.460","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314205"},{"key":"2025090711072529000_71.9.1724.461","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2018.00202","article-title":"Association between gut microbiota and Helicobacter pylori-related gastric lesions in a high-risk population of gastric cancer","volume":"8","author":"Gao","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"2025090711072529000_71.9.1724.462","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12547","article-title":"Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing","volume":"24","author":"Park","year":"2019","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.463","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15650"},{"key":"2025090711072529000_71.9.1724.464","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3390\/jcm9061882","article-title":"Transient and persistent gastric microbiome: adherence of bacteria in gastric cancer and dyspeptic patient biopsies after washing","volume":"9","author":"Spiegelhauer","year":"2020","journal-title":"J Clin Med"},{"key":"2025090711072529000_71.9.1724.465","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16289-2","article-title":"Dysbiosis of the microbiome in gastric carcinogenesis","volume":"7","author":"Casta\u00f1o-Rodr\u00edguez","year":"2017","journal-title":"Sci Rep"},{"key":"2025090711072529000_71.9.1724.466","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314281"},{"key":"2025090711072529000_71.9.1724.467","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.007302-0"},{"key":"2025090711072529000_71.9.1724.468","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12145"},{"key":"2025090711072529000_71.9.1724.469","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/hel.12293","article-title":"Analysis of gastric microbiota by pyrosequencing: minor role of bacteria other than Helicobacter pylori in the gastric carcinogenesis","volume":"21","author":"Jo","year":"2016","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.470","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319696"},{"key":"2025090711072529000_71.9.1724.471","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73448-8","article-title":"Fusobacterium nucleatum is associated with worse prognosis in Lauren\u2019s diffuse type gastric cancer patients","volume":"10","author":"Boehm","year":"2020","journal-title":"Sci Rep"},{"key":"2025090711072529000_71.9.1724.472","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006653"},{"key":"2025090711072529000_71.9.1724.473","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12521","article-title":"Other helicobacters and the gastric microbiome","volume":"23 Suppl 1","author":"Kupcinskas","year":"2018","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.474","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12744","article-title":"Review: other Helicobacter species","volume":"25 Suppl 1","author":"Smet","year":"2020","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.475","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12264"},{"key":"2025090711072529000_71.9.1724.476","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i5.1414"},{"key":"2025090711072529000_71.9.1724.477","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fmed.2019.00188","article-title":"Helicobacter suis Is Associated With Mortality in Parkinson\u2019s Disease","volume":"6","author":"Augustin","year":"2019","journal-title":"Front Med"},{"key":"2025090711072529000_71.9.1724.478","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/01635581.2019.1578394","article-title":"Microbiota diversity in human colorectal cancer tissues is associated with clinicopathological features","volume":"71","author":"Wu","year":"2019","journal-title":"Nutr Cancer"},{"key":"2025090711072529000_71.9.1724.479","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.2169\/internalmedicine.1196-18","article-title":"Bacteremia possibly caused by Helicobacter cinaedi and associated with painful erythema in rheumatoid arthritis with malignant lymphoma","volume":"57","author":"Fujita","year":"2018","journal-title":"Intern Med"},{"key":"2025090711072529000_71.9.1724.480","doi-asserted-by":"crossref","first-page":"230","DOI":"10.7150\/jbji.28375","article-title":"A Case Of Recurrent Helicobacter cinaedi Prosthetic Joint Infection In An HIV-Infected Man","volume":"3","author":"Kedra","year":"2018","journal-title":"J Bone Jt Infect"},{"key":"2025090711072529000_71.9.1724.481","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jdcr.2017.11.016","article-title":"Helicobacter cinaedi bacteremia mimicking eosinophilic fasciitis in a patient with X-linked agammaglobulinemia","volume":"4","author":"Hill","year":"2018","journal-title":"JAAD Case Rep"},{"key":"2025090711072529000_71.9.1724.482","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/hel.12259","article-title":"The other helicobacters","volume":"20 Suppl 1","author":"Flahou","year":"2015","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.483","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02533","article-title":"A Potential New Human Pathogen Belonging to Helicobacter Genus, Identified in a Bloodstream Infection","volume":"8","author":"van der Mee-Marquet","year":"2017","journal-title":"Front Microbiol"},{"key":"2025090711072529000_71.9.1724.484","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-020-01331-x","article-title":"Prevalence of non Helicobacter pylori gastric helicobacters in Iranian dyspeptic patients","volume":"20","author":"Shafaie","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"2025090711072529000_71.9.1724.485","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/00365529709025059","article-title":"A Comparison of Helicobacter pylori and H. heilmannii Gastritis: A Matched Control Study Involving 404 Patients","volume":"32","author":"Stolte","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.486","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.arcmed.2019.11.001","article-title":"Helicobacter heilmannii colonization is associated with high risk for gastritis","volume":"50","author":"Mohammadi","year":"2019","journal-title":"Arch Med Res"},{"key":"2025090711072529000_71.9.1724.487","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i12.3376"},{"key":"2025090711072529000_71.9.1724.488","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199803000-00011"},{"key":"2025090711072529000_71.9.1724.489","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0140-6736(95)91364-5","article-title":"Helicobacter heilmannii and gastric cancer","volume":"346","author":"Morgner","year":"1995","journal-title":"The Lancet"},{"key":"2025090711072529000_71.9.1724.490","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70167-3"},{"key":"2025090711072529000_71.9.1724.491","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12328-020-01310-5","article-title":"Gastric mucosa-associated lymphoid tissue lymphoma in conjunction with multiple lymphomatous polyposis in the context of Helicobacter pylori and Helicobacter suis superinfection","volume":"14","author":"Naito","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.492","first-page":"148","article-title":"[Helicobacter cinaedi bacteremia: Presentation of the first cases reported in Argentina]","volume":"51","author":"Togneri","year":"2019","journal-title":"Rev Argent Microbiol"},{"key":"2025090711072529000_71.9.1724.493","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz200","article-title":"Genome sequencing Verifies relapsed infection of Helicobacter cinaedi","volume":"6","author":"Sawada","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025090711072529000_71.9.1724.494","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2011.00849.x"},{"key":"2025090711072529000_71.9.1724.495","first-page":"411","article-title":"Gastrospirillum hominis (\"Helicobacter heilmanii\"): a cause of gastritis, sometimes transient, better diagnosed by touch cytology?","volume":"90","author":"Debongnie","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.496","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12645","article-title":"Review: Other Helicobacter species","volume":"24","author":"M\u00e9nard","year":"2019","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.497","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1038\/s41396-018-0199-5","article-title":"Macroevolution of gastric Helicobacter species unveils interspecies admixture and time of divergence","volume":"12","author":"Smet","year":"2018","journal-title":"Isme J"},{"key":"2025090711072529000_71.9.1724.498","doi-asserted-by":"publisher","DOI":"10.1080\/00365540701299608"},{"key":"2025090711072529000_71.9.1724.499","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01902","article-title":"Shifts in the Human Gut Microbiota Structure Caused by Quadruple Helicobacter pylori Eradication Therapy","volume":"10","author":"Olekhnovich","year":"2019","journal-title":"Front Microbiol"},{"key":"2025090711072529000_71.9.1724.500","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/jac\/dkz137","article-title":"Selective and suppressive effects of antibiotics on donor and recipient bacterial strains in gut microbiota determine transmission efficiency of blaNDM-1-bearing plasmids","volume":"74","author":"Ye","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2025090711072529000_71.9.1724.501","doi-asserted-by":"crossref","first-page":"e00903","DOI":"10.1128\/mBio.00903-19","article-title":"Mice fed an obesogenic Western diet, administered antibiotics, and subjected to a sterile surgical procedure develop lethal septicemia with multidrug-resistant Pathobionts","volume":"10","author":"Hyoju","year":"2019","journal-title":"mBio"},{"key":"2025090711072529000_71.9.1724.502","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220549","article-title":"Erythromycin-Resistant lactic acid bacteria in the healthy gut of vegans, ovo-lacto vegetarians and omnivores","volume":"14","author":"Milanovi\u0107","year":"2019","journal-title":"PLoS One"},{"key":"2025090711072529000_71.9.1724.503","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111030"},{"key":"2025090711072529000_71.9.1724.504","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3892\/etm.2015.2174","article-title":"Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: a meta-analysis","volume":"9","author":"Lv","year":"2015","journal-title":"Exp Ther Med"},{"key":"2025090711072529000_71.9.1724.505","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2036.2006.03179.x","article-title":"Meta-Analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy","volume":"25","author":"Tong","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.506","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318266f6cf"},{"key":"2025090711072529000_71.9.1724.507","doi-asserted-by":"publisher","DOI":"10.4321\/S1130-01082013000800002"},{"key":"2025090711072529000_71.9.1724.508","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12651"},{"key":"2025090711072529000_71.9.1724.509","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104403","article-title":"Meta-Analysis of the efficacy of probiotic-supplemented therapy on the eradication of H. pylori and incidence of therapy-associated side effects","volume":"147","author":"Zhang","year":"2020","journal-title":"Microb Pathog"},{"key":"2025090711072529000_71.9.1724.510","doi-asserted-by":"crossref","DOI":"10.1007\/s00431-014-2340-4","article-title":"Pooling data on different probiotics is not appropriate to assess the efficacy of probiotics","volume":"173","author":"Szajewska","year":"2014","journal-title":"Eur J Pediatr"},{"key":"2025090711072529000_71.9.1724.511","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04457.x"},{"key":"2025090711072529000_71.9.1724.512","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13214"},{"key":"2025090711072529000_71.9.1724.513","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093171","article-title":"A Randomised, Controlled Trial: Effect of a Multi-Strain Fermented Milk on the Gut Microbiota Recovery after Helicobacter pylori Therapy","volume":"13","author":"Guillemard","year":"2021","journal-title":"Nutrients"},{"key":"2025090711072529000_71.9.1724.514","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12856","article-title":"Effects of non-viable Lactobacillus reuteri combining with 14-day standard triple therapy on Helicobacter pylori eradication: a randomized double-blind placebo-controlled trial","volume":"26","author":"Yang","year":"2021","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.515","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2036.2002.0160s1024.x","article-title":"Review article: treatment of Helicobacter pylori infection and factors influencing eradication","volume":"16 Suppl 1","author":"Qasim","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711072529000_71.9.1724.516","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku243"},{"key":"2025090711072529000_71.9.1724.517","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283643491"},{"key":"2025090711072529000_71.9.1724.518","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2008.060392"},{"key":"2025090711072529000_71.9.1724.519","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00037-15"},{"key":"2025090711072529000_71.9.1724.520","doi-asserted-by":"publisher","DOI":"10.1067\/mpr.2001.113778"},{"key":"2025090711072529000_71.9.1724.521","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/0022034520924633","article-title":"The bacterial connection between the oral cavity and the gut diseases","volume":"99","author":"Kitamoto","year":"2020","journal-title":"J Dent Res"},{"key":"2025090711072529000_71.9.1724.522","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10620-020-06101-z","article-title":"Microbiome and gastric cancer","volume":"65","author":"Engstrand","year":"2020","journal-title":"Dig Dis Sci"},{"key":"2025090711072529000_71.9.1724.523","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/hel.12190","article-title":"Helicobacter pylori infection is positively associated with metabolic syndrome in Taiwanese adults: a cross-sectional study","volume":"20","author":"Chen","year":"2015","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.524","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/jgh.12617","article-title":"Gastric Helicobacter pylori infection associated with risk of diabetes mellitus, but not prediabetes","volume":"29","author":"Yang","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.525","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1523-5378.2012.00970.x","article-title":"Association of H. pylori Infection with Insulin Resistance and Metabolic Syndrome Among Lebanese Adults","volume":"17","author":"Naja","year":"2012","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.526","doi-asserted-by":"crossref","first-page":"JCM.S10828","DOI":"10.4137\/JCM.S10828","article-title":"The Eradication of Helicobacter pylori does not Affect Glycemic Control in Japanese Subjects with Type 2 Diabetes","volume":"4","author":"Wada","year":"2013","journal-title":"Jpn Clin Med"},{"key":"2025090711072529000_71.9.1724.527","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00535-017-1337-y","article-title":"A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease","volume":"52","author":"Kim","year":"2017","journal-title":"J Gastroenterol"},{"key":"2025090711072529000_71.9.1724.528","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/MEG.0000000000001398","article-title":"Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systemic review and meta-analysis","volume":"31","author":"Ning","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025090711072529000_71.9.1724.529","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-015-0247-9","article-title":"Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan","volume":"15","author":"Okushin","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"2025090711072529000_71.9.1724.530","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3892\/etm.2017.4028","article-title":"Association between Helicobacter pylori infection and angiographically demonstrated coronary artery disease: a meta-analysis","volume":"13","author":"XJ","year":"2017","journal-title":"Exp Ther Med"},{"key":"2025090711072529000_71.9.1724.531","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.11.029"},{"key":"2025090711072529000_71.9.1724.532","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6558-7"},{"key":"2025090711072529000_71.9.1724.533","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4291\/wjgp.v5.i4.400","article-title":"Helicobacter pylori and neurological diseases: married by the laws of inflammation","volume":"5","author":"Alvarez-Arellano","year":"2014","journal-title":"World J Gastrointest Pathophysiol"},{"key":"2025090711072529000_71.9.1724.534","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303018"},{"key":"2025090711072529000_71.9.1724.535","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jocn.2013.11.018","article-title":"Association between Helicobacter pylori infection and dementia","volume":"21","author":"Huang","year":"2014","journal-title":"J Clin Neurosci"},{"key":"2025090711072529000_71.9.1724.536","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jgs.12065","article-title":"Does Helicobacter pylori Infection Increase Incidence of Dementia? The Personnes Ag\u00e9es QUID Study","volume":"61","author":"Roubaud Baudron","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"2025090711072529000_71.9.1724.537","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0b013e31829108c3"},{"key":"2025090711072529000_71.9.1724.538","doi-asserted-by":"publisher","DOI":"10.1097\/WNN.0b013e3181df3034"},{"key":"2025090711072529000_71.9.1724.539","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5011-z"},{"key":"2025090711072529000_71.9.1724.540","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/dote.12364","article-title":"H elicobacter pylori -related ApoE 4 polymorphism may be associated with dysphagic symptoms in older adults","volume":"29","author":"Kountouras","year":"2016","journal-title":"Dis Esophagus"},{"key":"2025090711072529000_71.9.1724.541","first-page":"69","article-title":"Pathophysiologic relationship between Alzheimer\u2019s disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis","volume":"7","author":"Santos","year":"2017","journal-title":"Alzheimers Dement"},{"key":"2025090711072529000_71.9.1724.542","doi-asserted-by":"publisher","DOI":"10.1080\/00207450902782083"},{"key":"2025090711072529000_71.9.1724.543","doi-asserted-by":"crossref","first-page":"39437","DOI":"10.18632\/oncotarget.6254","article-title":"Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer\u2019s disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies","volume":"6","author":"Zelaya","year":"2015","journal-title":"Oncotarget"},{"key":"2025090711072529000_71.9.1724.544","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-014-1261-7"},{"key":"2025090711072529000_71.9.1724.545","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3233\/JAD-2009-1036","article-title":"MRI-Derived Atrophy of the Olfactory Bulb and Tract in Mild Cognitive Impairment and Alzheimer\u2019s Disease","volume":"17","author":"Thomann","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"2025090711072529000_71.9.1724.546","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3233\/JAD-2010-091549","article-title":"Functional Representation of Olfactory Impairment in Early Alzheimer\u2019s Disease","volume":"22","author":"F\u00f6rster","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"2025090711072529000_71.9.1724.547","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/469097"},{"key":"2025090711072529000_71.9.1724.548","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-5957-5"},{"key":"2025090711072529000_71.9.1724.549","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4081\/ni.2013.e10","article-title":"Relation of Helicobacter pylori infection and multiple sclerosis in Iranian patients","volume":"5","author":"Mohebi","year":"2013","journal-title":"Neurol Int"},{"key":"2025090711072529000_71.9.1724.550","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.00052","article-title":"Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis","volume":"6","author":"Cook","year":"2015","journal-title":"Front Microbiol"},{"key":"2025090711072529000_71.9.1724.551","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12398","article-title":"Meta-Analysis: association of Helicobacter pylori infection with Parkinson's diseases","volume":"22","author":"Shen","year":"2017","journal-title":"Helicobacter"},{"key":"2025090711072529000_71.9.1724.552","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.parkreldis.2017.11.331","article-title":"Helicobacter pylori infection is associated with an increased risk of Parkinson\u2019s disease: A population-based retrospective cohort study","volume":"47","author":"Huang","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"2025090711072529000_71.9.1724.553","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25522"},{"key":"2025090711072529000_71.9.1724.554","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.parkreldis.2014.12.009","article-title":"Helicobacter pylori infection is associated with worse severity of Parkinson's disease","volume":"21","author":"Tan","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"2025090711072529000_71.9.1724.555","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3988\/jcn.2017.13.2.181","article-title":"Association of Helicobacter pylori with Parkinson's disease","volume":"13","author":"Mridula","year":"2017","journal-title":"J Clin Neurol"},{"key":"2025090711072529000_71.9.1724.556","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.127035"},{"key":"2025090711072529000_71.9.1724.557","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00011-009-8075-4","article-title":"In vitro effects of Helicobacter pylori-induced infection in gastric epithelial AGS cells on microglia-mediated toxicity in neuroblastoma SH-SY5Y cells","volume":"58","author":"YC","year":"2009","journal-title":"Inflamm Res"},{"key":"2025090711072529000_71.9.1724.558","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1999.tb00721.x"},{"key":"2025090711072529000_71.9.1724.559","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2004.00977.x"},{"key":"2025090711072529000_71.9.1724.560","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.2000.0490"},{"key":"2025090711072529000_71.9.1724.561","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.73.1.76"},{"key":"2025090711072529000_71.9.1724.562","doi-asserted-by":"publisher","DOI":"10.1177\/2050640614559262"},{"key":"2025090711072529000_71.9.1724.563","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-4362.2003.01817.x","article-title":"Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients","volume":"42","author":"Argenziano","year":"2003","journal-title":"Int J Dermatol"},{"key":"2025090711072529000_71.9.1724.564","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1346-8138.2012.01675.x","article-title":"Role of Helicobacter pylori in common rosacea subtypes: a genotypic comparative study of Egyptian patients","volume":"39","author":"El-Khalawany","year":"2012","journal-title":"J Dermatol"},{"key":"2025090711072529000_71.9.1724.565","first-page":"133","article-title":"Psoriasis and Helicobacter pylori","volume":"69","author":"Qayoom","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2025090711072529000_71.9.1724.566","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1590\/abd1806-4841.20174880","article-title":"Relationship of Helicobacter pylori seroprevalence with the occurrence and severity of psoriasis","volume":"92","author":"Mesquita","year":"2017","journal-title":"An Bras Dermatol"},{"key":"2025090711072529000_71.9.1724.567","doi-asserted-by":"crossref","DOI":"10.1590\/abd1806-4841.2017112","article-title":"Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasis","volume":"92","author":"Ribaldone","year":"2017","journal-title":"An Bras Dermatol"},{"key":"2025090711072529000_71.9.1724.568","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1684\/ejd.2011.1579","article-title":"Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment","volume":"22","author":"Onsun","year":"2012","journal-title":"Eur J Dermatol"},{"key":"2025090711072529000_71.9.1724.569","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1111\/ijd.12798","article-title":"Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature","volume":"54","author":"Campanati","year":"2015","journal-title":"Int J Dermatol"},{"key":"2025090711072529000_71.9.1724.570","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5144\/0256-4947.2014.241","article-title":"Relationship between Helicobacter pylori infection and psoriasis","volume":"34","author":"Azizzadeh","year":"2014","journal-title":"Ann Saudi Med"},{"key":"2025090711072529000_71.9.1724.571","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-4362.2000.00979.x","article-title":"The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria","volume":"39","author":"Hizal","year":"2000","journal-title":"Int J Dermatol"},{"key":"2025090711072529000_71.9.1724.572","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2006.04646.x"},{"key":"2025090711072529000_71.9.1724.573","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2332\/allergolint.13-OA-0580","article-title":"Eradication therapy for urticaria with high titers of anti H. pylori IgG antibody","volume":"63","author":"Yoshimasu","year":"2014","journal-title":"Allergol Int"},{"key":"2025090711072529000_71.9.1724.574","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2340\/00015555-1373","article-title":"Role of small intestinal bacterial overgrowth and Helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis","volume":"93","author":"Campanati","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"2025090711072529000_71.9.1724.575","doi-asserted-by":"crossref","first-page":"107","DOI":"10.15171\/mejdd.2017.59","article-title":"Association between Helicobacter Pylori Infection and Alopecia Areata: A Study in Iranian Population","volume":"9","author":"Behrangi","year":"2017","journal-title":"Middle East J Dig Dis"},{"key":"2025090711072529000_71.9.1724.576","doi-asserted-by":"crossref","DOI":"10.1067\/mjd.2002.117255","article-title":"No increased prevalence of Helicobacter pylori in patients with alopecia areata","volume":"46","author":"Rigopoulos","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"2025090711072529000_71.9.1724.577","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.04.003"},{"key":"2025090711072529000_71.9.1724.578","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1111\/ijd.12869","article-title":"Frequency of seropositivity against infectious agents amongst pemphigus vulgaris patients: a case-control study on Strongyloides stercoralis, Helicobacter pylori, Toxoplasma gondii, Leishmania major, and Epstein-Barr virus","volume":"54","author":"Mortazavi","year":"2015","journal-title":"Int J Dermatol"},{"key":"2025090711072529000_71.9.1724.579","doi-asserted-by":"publisher","DOI":"10.1080\/08916930232000114535"},{"key":"2025090711072529000_71.9.1724.580","first-page":"291","article-title":"Henoch-Sch\u00f6nlein purpura in an adult patient: extragastric, cutaneous manifestation of Helicobacter pylori infection","volume":"29","author":"Grivceva-Panovska","year":"2008","journal-title":"Prilozi"},{"key":"2025090711072529000_71.9.1724.581","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2169\/internalmedicine.48.1718","article-title":"Adult onset Sch\u00f6nlein-Henoch purpura associated with Helicobacter pylori infection","volume":"48","author":"Hoshino","year":"2009","journal-title":"Intern Med"},{"key":"2025090711072529000_71.9.1724.582","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1167\/iovs.15-17059","article-title":"The relationship between Helicobacter pylori infection and open-angle glaucoma: a meta-analysis","volume":"56","author":"Zeng","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025090711072529000_71.9.1724.583","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00093-9"},{"key":"2025090711072529000_71.9.1724.584","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31815a34ac"},{"key":"2025090711072529000_71.9.1724.585","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.6061\/clinics\/2012(09)11","article-title":"Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy","volume":"67","author":"Casella","year":"2012","journal-title":"Clinics"},{"key":"2025090711072529000_71.9.1724.586","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IAE.0000000000000837","article-title":"Risk factors for central serous chorioretinopathy: a systematic review and meta-analysis","volume":"36","author":"Liu","year":"2016","journal-title":"Retina"},{"key":"2025090711072529000_71.9.1724.587","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/112067210601600213","article-title":"Central serous chorioretinopathy and Helicobacter pylori","volume":"16","author":"Cotticelli","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"2025090711072529000_71.9.1724.588","first-page":"99","article-title":"The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy","volume":"17","author":"Rahbani-Nobar","year":"2011","journal-title":"Mol Vis"},{"key":"2025090711072529000_71.9.1724.589","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/TCRM.S50407","article-title":"The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients","volume":"9","author":"Dang","year":"2013","journal-title":"Ther Clin Risk Manag"},{"key":"2025090711072529000_71.9.1724.590","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00417-016-3315-0","article-title":"Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy","volume":"254","author":"Zavoloka","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2025090711072529000_71.9.1724.591","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-0323"},{"key":"2025090711072529000_71.9.1724.592","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000216","article-title":"Helicobacter pylori infection and eye diseases: a systematic review","volume":"93","author":"Sacc\u00e0","year":"2014","journal-title":"Medicine"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2022-327745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T18:08:20Z","timestamp":1757268500000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2022-327745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":592,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,8,11]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/gutjnl-2022-327745"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2022-327745","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,8]]}}}